RCT for the Efficacy of Soothing Cream Jel in Improving Upper Limb Pain and Motion
CompletedPhase 2NCT05799391
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This is a randomized, double-blinded, placebo-controlled clinical trial. This trial is used to evaluate the efficacy of soothing cream jel on chronic upper limb pain and the range of motion.
Study details
- Official title
- Efficacy of Soothing Cream Jel in Improving the Range of Motion and Chronic Pain at Shoulder and Elbow: A Double-blinded, Randomized, Placebo-Controlled Trial
- Conditions
- Upper Extremity Problem
- Interventions
- Drug: SJC
- Other: Placebo
- Sponsor
- Chinese University of Hong Kong
- Start date
- 2023-07-10
- Primary completion
- 2024-05-10
- Sex
- All
- Age range
- from 18 Years to 60 Years
- Results posted
- No results posted in this snapshot
- Countries
- Hong Kong
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Age 18-60; 2. Participates in regular physical activity, at least once a week for 30 minutes; 3. Chronic pain in the shoulder or elbow longer than 3 months; 4. 11-items Numeric pain rating scale ≥4; and 5. Willing to provide written informed consent. Exclusion Criteria: 1. The patient had received previous physiotherapy, acupuncture, Tui Na massage, or bone-setting treatment for distal upper limb pain within the past 2 weeks; 2. The pain was due to a fracture or known complex regional pain syndrome. 3. History of upper limb surgery; 4. Known severe medical conditions (e.g. rheumatoid arthritis, osteoporosis, cardiac, renal, hepatic, hematological diseases, vertigo, seizure, infection, malignancy, neurological impairment); 5. Concomitant drugs of NSAIDs, any kind of painkillers, or anti-inflammatory drugs 15 days prior to randomization; 6. Known impaired hematological profile and liver / renal function; 7. Known allergic history to any topical cream; 8. Known pregnant or lactating; or 9. Unable to complete questionnaires
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05799391